Sasagawa S
Department of Pathology, Radiation Effects Research Foundation, Hiroshima, Japan.
Immunopharmacol Immunotoxicol. 1991;13(4):607-22. doi: 10.3109/08923979109019726.
This study examined the effects of four typical local anesthetics, lidocaine, prilocaine, procaine and tetracaine, on the functioning of human polymorphonuclear leukocytes (PMN). PMN were stimulated by fMet-Leu-Phe (FMLP) or phorbol myristate acetate (PMA) to elicit chemotaxis, extracellular release of beta-glucuronidase (BGL) and superoxide anion (SOA) production. The four agents inhibited chemotaxis efficiently and in a concentration-dependent manner but had only weak effects on the release of BGL. The effect of tetracaine was strongest, followed by lidocaine, then prilocaine, whereas the effect of procaine was blunt. The 50% inhibitory concentrations (IC50 in molarity) of the four local anesthetics for chemotaxis were as follows: tetracaine = 4.1 x 10(-4), lidocaine = 3.2 x 10(-3), prilocaine = 3.6 x 10(-3), procaine = 4.9 x 10(-3), those for SOA production induced by FMLP were: tetracaine = 3.1 x 10(-4), lidocaine = 5.9 x 10(-3), prilocaine = 1.9 x 10(-2), procaine = 1.2 x 10(-2), those for SOA production induced by PMA were: tetracaine = 1.1 x 10(-3), lidocaine = 1.2 x 10(-2), prilocaine = 1.5 x 10(-2), procaine = 2.5 x 10(-2), and those for release of BGL were: tetracaine = 1.6 x 10(-3), lidocaine = 5.3 x 10(-3), prilocaine = 2.8 x 10(-2), procaine = 1.2 x 10(-1). The IC50 seemed to relate to the anesthetic's chemical structures and their inhibitory properties on PMN functions, as lidocaine and prilocaine, which are aminoamide type anesthetics, preferentially inhibited chemotaxis, whereas tetracaine and procaine, aminoester type anesthetics, inhibited SOA production induced by FMLP. The results suggest that the inhibitory effects of local anesthetics on human PMN functions are also correlated with local anesthetic potency and vary according to differences in their chemical structures.
本研究考察了四种典型的局部麻醉药,即利多卡因、丙胺卡因、普鲁卡因和丁卡因,对人多形核白细胞(PMN)功能的影响。用甲酰甲硫氨酸-亮氨酸-苯丙氨酸(FMLP)或佛波酯(PMA)刺激PMN以引发趋化作用、β-葡萄糖醛酸酶(BGL)的细胞外释放以及超氧阴离子(SOA)的产生。这四种药物能有效抑制趋化作用,且呈浓度依赖性,但对BGL的释放影响较弱。丁卡因的作用最强,其次是利多卡因,然后是丙胺卡因,而普鲁卡因的作用不明显。四种局部麻醉药对趋化作用的50%抑制浓度(IC50,单位为摩尔浓度)如下:丁卡因=4.1×10⁻⁴,利多卡因=3.2×10⁻³,丙胺卡因=3.6×10⁻³,普鲁卡因=4.9×10⁻³;对FMLP诱导的SOA产生的IC50分别为:丁卡因=3.1×10⁻⁴,利多卡因=5.9×10⁻³,丙胺卡因=1.9×10⁻²,普鲁卡因=1.2×10⁻²;对PMA诱导的SOA产生的IC50分别为:丁卡因=1.1×10⁻³,利多卡因=1.2×10⁻²,丙胺卡因=1.5×10⁻²,普鲁卡因=2.5×10⁻²;对BGL释放的IC50分别为:丁卡因=1.6×10⁻³,利多卡因=5.3×10⁻³,丙胺卡因=2.8×10⁻²,普鲁卡因=1.2×10⁻¹。IC50似乎与麻醉药的化学结构及其对PMN功能的抑制特性有关,因为作为酰胺类麻醉药的利多卡因和丙胺卡因优先抑制趋化作用,而作为酯类麻醉药的丁卡因和普鲁卡因则抑制FMLP诱导的SOA产生。结果表明,局部麻醉药对人PMN功能的抑制作用也与局部麻醉效能相关,并因化学结构的差异而有所不同。